Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 657
Titolo Data di pubblicazione Autore(i) File
High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study. 1997 A. M. Vannucchi; A. Bosi; S. Linari; S. Guidi; G. Longo; L. Lombardini; M. P. Mariani; R. Saccardi; D. Laszlo; P. Rossi Ferrini
Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. 1997 ASHIHARA E.; A. VANNUCCHI; MIGLIACCIO G.; MIGLIACCIO A.R.
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients. 1997 D. Laszlo; S. Bacci; A. Bosi; R. Fanci; S. Guidi; R. Saccardi; A. M. Vannucchi; P. Rossi Ferrini
Pretransplant factor XII levels correlate with prognosis in patients undergoing autologous graft for hematological malignancies. 1997 G. Longo; E. Filimberti; S. Cinotti; A. M. Vannucchi; L. Lombardini; P. R. Ferrini
An erythroid and megakaryocytic common precursor cell line (B1647) expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates and modifies globin chain synthesis in response to megakaryocyte growth and development factor (MGDF) but not to erythropoietin (Epo). 1997 BONSI L.; GROSSI A.; STRIPPOLI P.; TUMIETTO F.; TONELLI R.; A. VANNUCCHI; RONCHI A.; OTTOLENGHI S.; VISCONTI G.; AVANZI G.C.; PEGORARO L.; BAGNARA G.P.
Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias. 1998 S. Linari; A. M. Vannucchi; S. Ciolli; F. Leoni; R. Caporale; A. Grossi; G. Pagliai; V. Santini; F. Paoletti; P. R. Ferrini
Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant. 1998 A. Bosi; M. Zazzi; A. Amantini; M. Cellerini; A. M. Vannucchi; A. De Milito; S. Guidi; R. Saccardi; L. Lombardini; D. Laszlo; P. Rossi Ferrini
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. 1998 Rossi Ferrini P; Grossi A; Vannucchi AM; Barosi G; Guarnone R; Piva N; Musto P; Balleari E
Erythropoietin upregulates the expression of its own receptor in TF-1 cell line 1998 GROSSI A.; A. VANNUCCHI; BACCI P.; CAPORALE R.; CAPPELLI G.; VISCONTI G.; PAGLIAI G.; FERRINI PR.
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. 1998 A. M. Vannucchi; A. Bosi; S. Glinz; P. Pacini; S. Linari; R. Saccardi; R. Alterini; L. Rigacci; S. Guidi; L. Lombardini; G. Longo; M. P. Mariani; P. Rossi-Ferrini
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia. 1999 A. Bosi; D. Laszlo; S. Bacci; R. Fanci; S. Guidi; R. Saccardi; A. M. Vannucchi; P. Rossi-Ferrini
Detection of contaminating tumor cells by RT-PCR in breast cancer patients. 1999 A. M. Vannucchi; S. Glinz; A. Bosi; C. Fallai; P. Rossi-Ferrini
Increased expression of the distal, but not of the proximal, Gata1 transcripts during differentiation of primary erythroid cells. 1999 A. VANNUCCHI; LINARI S.; LIN C-S.; KOURY M.J.; BONDURANT M.C.; MIGLIACCIO A.R.
Constitutive muscarinic receptors are involved in the growth and differentiation of friend erythroleukemia cells. 1999 C. Cellai; R. Matucci; A. M. Vannucchi; F. Paoletti
Identification and characterization of a bipotent (eryhtroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. 2000 A. VANNUCCHI; F. PAOLETTI; C. CELLAI; R. CAPORALE; M. SANCHEZ; S. LINARI; P. ROSSI FERRINI; G. MIGLIACCIO; A. MIGLIACCIO
Selective ex vivo expansion of cytomegalovirus/specific CD4 and CD8 T lymphocytes using dendritic cells pulsed with a human leukocyte antigen A201 restricted peptide 2001 A. VANNUCCHI; GLINZ S; BOSI A; CAPORALE R; ROSSI FERRINI P
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their Gata-1 expressione (GATA-1low mice). 2001 A. VANNUCCHI; L. BIANCHI; C. CELLAI; F. PAOLETTI; V. CARRAI; A. CALZOLARI; L. CENTURIONE; R. LORENZINI; C. CARTA; E. ALFANI; M. SANCHEZ; G. MIGLIACCIO; A. MIGLIACCIO
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells 2002 F. PAOLETTI; A. VANNUCCHI; L. BIANCHI; N. DELLA MALVA; C. CELLAI; A. LAURENZANA
DEVELOPMENT OF MYELOFIBROSIS IN MICE GENETICALLY IMPAIRED FOR GATA-1 EXPRESSION (GATA-1LOW) MICE. 2002 A. VANNUCCHI; L. BIANCHI; C. CELLAI; F. PAOLETTI; R. RANA; R. LORENZINI; G. MIGLIACCIO; A. MIGLIACCIO
Polymerase chain reaction-based "pre-emptive" therapy with cidofovir for cytomegalovirus reactivation in allogeneic hematopoietic stem cells transplantation recipients: a prospective study. 2002 Bosi A; Bartolozzi B; Vannucchi AM; Orsi A; Guidi S; Rossi Ferrini P.
Mostrati risultati da 61 a 80 di 657
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile